BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2230926
,
PRKCA
,
cell-cell adhesion
,
Diabetes mellitus
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
7163-50-0
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for 7163-50-0
Explore Curated Studies Results
Literature
Most Relevant Literature
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in …
q-space MR imaging of gastric carcinoma ex vivo: Correlation with histopathologic findings.
Esophageal carcinoma: Evaluation with q-space diffusion-weighted MR imaging ex vivo.
The Diagnosis of Urinary Tract infection in Young children (DUTY): a diagnostic prospective observat…
An evaluation of hepatotoxicity in breast cancer patients receiving injection Doxorubicin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmenta…
Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronar…
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibi…
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Gliobl…
9-ING-41 in Pediatric Patients With Refractory Malignancies.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ